Journal article
Chronic very low dose naltrexone administration attenuates opioid withdrawal expression
Biological psychiatry (1969), v 56(4), pp 261-268
15 Aug 2004
PMID: 15312814
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Different regimens of agonist and antagonist drugs have been used in opioid withdrawal management, with variable results. We examined whether administering extremely small quantities of opiate antagonists in the presence of opiate agonist drugs reduces withdrawal expression.
Forty-one male Sprague-Dawley rats were implanted with morphine or placebo pellets for eight days. Starting on day 3, some rats received naltrexone in their drinking water (5 mg/L), or unadulterated water. On day 8, rats were injected with saline or naltrexone (100 mg/kg) and evaluated for behavioral signs of withdrawal. Next, sections through the locus coeruleus (LC) and nucleus of the solitary tract (NTS), brainstem areas exhibiting cellular activation following opiate withdrawal, were processed for c-Fos to detect early gene expression. Finally, the same nuclei were examined for protein kinase A regulatory subunit II (PKA) and phosphorylated cyclic adenosine monophosphate response element binding protein (pCREB), using Western blot analysis.
Withdrawal was attenuated and c-Fos, PKA, and pCREB expression was decreased in the NTS and LC of rats receiving chronic very low doses of naltrexone.
Reduction of withdrawal upon chronic very low naltrexone administration may be due in part to decreased activation of brainstem noradrenergic neurons in morphine dependent rats.
Metrics
Details
- Title
- Chronic very low dose naltrexone administration attenuates opioid withdrawal expression
- Creators
- Paolo Mannelli - Thomas Jefferson UniversityEdward Gottheil - Thomas Jefferson UniversityJames F Peoples - Thomas Jefferson UniversityVeronica C Oropeza - Thomas Jefferson UniversityElisabeth J Van Bockstaele - Jefferson Hospital for Neuroscience
- Publication Details
- Biological psychiatry (1969), v 56(4), pp 261-268
- Publisher
- Elsevier
- Number of pages
- 8
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:000223327300008
- Scopus ID
- 2-s2.0-4143072464
- Other Identifier
- 991021903289504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Neurosciences
- Psychiatry